Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SciClone Pharmaceuticals Is Dramatically Increasing Profits
Seeking Alpha
Monday, April 9, 2012 - 5:46pm
tags:
SciClone
FDA will take 3 more months to review Vivus drug
Yahoo/AP
Monday, April 9, 2012 - 5:43pm
tags:
Vivus, FDA, Qnexa, obesity
Will Human Genome End Up Blazing A Trail For Others?
Seeking Alpha
Monday, April 9, 2012 - 5:43pm
tags:
Human Genome Sciences, GSK, Eli Lilly, Benlysta, Anthera, Immunomedics, lupus
Provenge And The Immunodepletion Theory: The Facts
Seeking Alpha
Monday, April 9, 2012 - 1:08pm
tags:
Provenge, Dendreon, immunodepletion, prostate cancer
Johnson & Johnson: Valuing The Dividends
Seeking Alpha
Monday, April 9, 2012 - 1:03pm
tags:
dividends, JNJ
Optimer fires chairman, CFO; shares fall
Yahoo/Reuters
Monday, April 9, 2012 - 12:23pm
tags:
Optimer
Icahn says sues Amylin, urges sale
Reuters
Monday, April 9, 2012 - 12:22pm
tags:
Amylin, Carl Icahn
Vertex Pharmaceuticals Could See Strong Gains From Incivek
Seeking Alpha
Monday, April 9, 2012 - 12:15pm
tags:
Incivek, Vertex Pharmaceuticals, Dendreon, JNJ, hepatitis C, Achillion
Why InterMune Shares Plunged
Motley Fool
Monday, April 9, 2012 - 12:14pm
tags:
InterMune, Esbriet
Dara BioSciences to raises $10.1M in a direct offering
The Fly on the Wall
Monday, April 9, 2012 - 12:13pm
tags:
DARA Biosciences, stock offering
Merck Can Sue State For Outsourcing Vioxx Lawsuits
Pharmalot
Monday, April 9, 2012 - 12:10pm
tags:
Vioxx, lawsuits, Merck
AstraZeneca faces calls for shake-up
FT.com
Monday, April 9, 2012 - 12:09pm
tags:
AstraZeneca
4 Biotech Stocks Outperforming Vertex
Seeking Alpha
Monday, April 9, 2012 - 12:08pm
tags:
Vertex Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb, Gilead, JNJ
Ampio Pharmaceuticals Follows Multiple Pipeline Strategies With Potential
Seeking Alpha
Monday, April 9, 2012 - 12:02pm
tags:
Ampio, Zertane
Bristol-Gilead Hep C Drug Data Leaks
TheStreet.com
Monday, April 9, 2012 - 12:01pm
tags:
Gilead, hepatitis C, Bristol-Myers Squibb, daclatasvir, GS-7977
Amgen And AstraZeneca To Collaborate On Inflammation Portfolio
Seeking Alpha
Monday, April 9, 2012 - 12:00pm
tags:
Amgen, AstraZeneca, inflammation
Lilly test tied to Alzheimer's is cleared by FDA
Marketwatch
Monday, April 9, 2012 - 11:59am
tags:
FDA, Eli Lilly, Alzheimer's disease, Amyvid
Arena Pharmaceuticals: A Stock For Aggressive Investors
Seeking Alpha
Monday, April 9, 2012 - 11:58am
tags:
Arena Pharmaceuticals, Abbott Laboratories, GSK, Sanofi
Vivus: Ready To Gain From Qnexa
Seeking Alpha
Monday, April 9, 2012 - 11:57am
tags:
Vivus, Qnexa, obesity, JNJ, Novartis, Pfizer, Teva Pharmaceuticals
Watch Achillion Pharmaceutical For Upcoming Phase IIa Data
Forex Pros
Sunday, April 8, 2012 - 12:44pm
tags:
Achillion, ACH-1625, HCV, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.